NO996035L - Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen - Google Patents

Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen

Info

Publication number: NO996035L
Authority: NO; Norway
Prior art keywords: diarrhea; procedure; treatment; large intestine; bacterial populations
Prior art date: 1997-06-09

Application number

NO996035A

Other languages

English (en)

Norwegian (no)

Other versions

NO996035D0 (no

Inventor

Beth P Goldstein

Original Assignee

Ambi Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-09

Filing date

1999-12-08

Publication date

1999-12-08

1999-12-08 Application filed by Ambi Inc filed Critical Ambi Inc

1999-12-08 Publication of NO996035D0 publication Critical patent/NO996035D0/no

1999-12-08 Publication of NO996035L publication Critical patent/NO996035L/no

Links

206010012735 Diarrhoea Diseases 0.000 title 1
230000001580 bacterial effect Effects 0.000 title 1
210000002429 large intestine Anatomy 0.000 title 1
108010062877 Bacteriocins Proteins 0.000 abstract 1
241000193163 Clostridioides difficile Species 0.000 abstract 1
DWPCPZJAHOETAG-IMJSIDKUSA-N L-lanthionine Chemical compound OC(=O)[C@@H](N)CSC[C@H](N)C(O)=O DWPCPZJAHOETAG-IMJSIDKUSA-N 0.000 abstract 1
108010053775 Nisin Proteins 0.000 abstract 1
NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 abstract 1
108010059993 Vancomycin Proteins 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
DWPCPZJAHOETAG-UHFFFAOYSA-N meso-lanthionine Natural products OC(=O)C(N)CSCC(N)C(O)=O DWPCPZJAHOETAG-UHFFFAOYSA-N 0.000 abstract 1
239000004309 nisin Substances 0.000 abstract 1
235000010297 nisin Nutrition 0.000 abstract 1
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 abstract 1
229960003165 vancomycin Drugs 0.000 abstract 1
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Plant Substances (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO996035A 1997-06-09 1999-12-08 Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen NO996035L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4923697P	1997-06-09	1997-06-09
US08/950,225 US5985823A (en)	1997-06-09	1997-10-14	Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
PCT/US1998/011820 WO1998056398A2 (en)	1997-06-09	1998-06-08	A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon

Publications (2)

Publication Number	Publication Date
NO996035D0 NO996035D0 (no)	1999-12-08
NO996035L true NO996035L (no)	1999-12-08

Family

ID=26726981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996035A NO996035L (no)	1997-06-09	1999-12-08	Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen

Country Status (16)

Country	Link
US (1)	US5985823A (de)
EP (1)	EP0983079B1 (de)
JP (1)	JP2002504906A (de)
CN (1)	CN1264306A (de)
AT (1)	ATE289821T1 (de)
AU (1)	AU7826298A (de)
BR (1)	BR9810861A (de)
CA (1)	CA2291645A1 (de)
DE (1)	DE69829179T2 (de)
IL (1)	IL132933A0 (de)
NO (1)	NO996035L (de)
PL (1)	PL337779A1 (de)
PT (1)	PT983079E (de)
SK (1)	SK169499A3 (de)
TW (1)	TW505515B (de)
WO (1)	WO1998056398A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL1013861C2 (nl) *	1999-12-15	2001-06-18	Stichting Tech Wetenschapp	Toepassing van Nisine of derivaat daarvan.
SI21221A (sl) *	2002-06-21	2003-12-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Hitro razpadljive tablete
AP2005003346A0 (en) *	2002-12-10	2005-06-30	Biosynexus Inc	Topical anti-infective formulations
EP1750740A4 (de) *	2004-05-06	2009-06-10	Molichem Medicines Inc	Behandlung von membran-bedingten erkrankungen und störungen unter verwendung von lantibiotikum enthaltenden zusammensetzungen
ITMI20041295A1 (it) *	2004-06-25	2004-09-25	Cosmo Spa	Composizioni farmaceutiche antimicrobiche orali
EP1940454A4 (de) *	2005-09-28	2012-01-04	Ventria Bioscience	Orale formulierung für enterische erkrankungen und/oder zur rehydratation
GB0600928D0 (en)	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
US20070238652A1 (en) *	2006-02-08	2007-10-11	Biosynexus Incorporated	Neutralization of bacterial spores
ITMI20060678A1 (it) *	2006-04-06	2007-10-07	Sanofi Aventis Otc S P A	Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714030D0 (en) *	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) *	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
WO2009037264A2 (en) *	2007-09-17	2009-03-26	Da Volterra	Colonic delivery of antimicrobial agents
ES2520165T3 (es) *	2009-01-14	2014-11-11	Novacta Biosystems Limited	Derivados de desoxiactagardina
CN102388060B (zh)	2009-02-04	2014-09-10	诺瓦克塔生物系统有限公司	阿肽加定衍生物
GB201001688D0 (en)	2010-02-02	2010-03-17	Novacta Biosystems Ltd	Compounds
JP2013531026A (ja)	2010-07-14	2013-08-01	ノヴァクタバイオシステムズリミティッド	Ｂ型ランチビオティックを含む製剤
GB201013513D0 (en)	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Formulations
CN105473608A (zh) *	2013-03-14	2016-04-06	阿维德百奥提克斯股份有限公司	艰难梭菌素及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5304540A (en) *	1988-06-22	1994-04-19	Applied Microbiology, Inc.	Pharmaceutical bacteriocin compositions and methods for using the same
US5260271A (en) *	1988-06-22	1993-11-09	Applied Microbiology, Inc.	Nisin compositions for use as enhanced broad range bactericides
IL104364A (en) *	1992-01-17	1997-09-30	Applied Microbiology	Pharmaceutical compositions containing bacteriocins
DE69629691T2 (de) *	1995-06-23	2004-02-26	Ambi, Inc.	Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
US5910479A (en) *	1996-10-18	1999-06-08	Ambi Inc.	Method for the treatment of Streptococcus pneumoniae infection

1997
- 1997-10-14 US US08/950,225 patent/US5985823A/en not_active Expired - Lifetime
1998
- 1998-06-06 TW TW087108997A patent/TW505515B/zh not_active IP Right Cessation
- 1998-06-08 AU AU78262/98A patent/AU7826298A/en not_active Abandoned
- 1998-06-08 CA CA002291645A patent/CA2291645A1/en not_active Abandoned
- 1998-06-08 EP EP98926418A patent/EP0983079B1/de not_active Expired - Lifetime
- 1998-06-08 CN CN98805829A patent/CN1264306A/zh active Pending
- 1998-06-08 PL PL98337779A patent/PL337779A1/xx not_active IP Right Cessation
- 1998-06-08 JP JP50303799A patent/JP2002504906A/ja not_active Ceased
- 1998-06-08 AT AT98926418T patent/ATE289821T1/de not_active IP Right Cessation
- 1998-06-08 DE DE69829179T patent/DE69829179T2/de not_active Expired - Fee Related
- 1998-06-08 PT PT98926418T patent/PT983079E/pt unknown
- 1998-06-08 BR BR9810861-1A patent/BR9810861A/pt not_active Application Discontinuation
- 1998-06-08 SK SK1694-99A patent/SK169499A3/sk unknown
- 1998-06-08 WO PCT/US1998/011820 patent/WO1998056398A2/en not_active Ceased
- 1998-06-08 IL IL13293398A patent/IL132933A0/xx unknown
1999
- 1999-12-08 NO NO996035A patent/NO996035L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PT983079E (pt)	2005-06-30
CN1264306A (zh)	2000-08-23
EP0983079A2 (de)	2000-03-08
JP2002504906A (ja)	2002-02-12
PL337779A1 (en)	2000-09-11
SK169499A3 (en)	2001-03-12
DE69829179D1 (de)	2005-04-07
WO1998056398A2 (en)	1998-12-17
DE69829179T2 (de)	2005-07-21
AU7826298A (en)	1998-12-30
BR9810861A (pt)	2001-04-24
EP0983079B1 (de)	2005-03-02
US5985823A (en)	1999-11-16
IL132933A0 (en)	2001-03-19
ATE289821T1 (de)	2005-03-15
WO1998056398A3 (en)	1999-03-25
NO996035D0 (no)	1999-12-08
TW505515B (en)	2002-10-11
CA2291645A1 (en)	1998-12-17

Legal Events

Date	Code	Title	Description
2004-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO996035D0 (no)	1999-12-08	Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen
DE69831506D1 (en)	2005-10-13	4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
IL148079A0 (en)	2002-09-12	Human ctla-4 antibodies and compositions containing the same
DE69636228D1 (de)	2006-07-20	Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
AP9200410A0 (en)	1992-07-31	Retroviral protease inhibitors.
NO976028L (no)	1997-12-22	Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon
DK0805685T3 (da)	2001-11-19	Hidtil ukendte antifungale cyclohexapeptider
ATE258057T1 (de)	2004-02-15	Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
MX9708611A (es)	1998-02-28	Compuestos de dialquiltiacumicina.
CY2225B1 (en)	2003-04-18	Organic compounds
DE69330268D1 (de)	2001-07-05	Hämoregulierende peptide
EA199800558A1 (ru)	1998-12-24	Композиция для криоконсервации органов и лечения вирусных и бактериальных инфекций
NO943765L (no)	1995-04-10	Aryloksybenzen-herbicidmidler
ES535471A0 (es)	1986-06-16	Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas.
BR9611520A (pt)	1999-12-28	Composto hemo-reguladores.